<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">transplantologiya</journal-id><journal-title-group><journal-title xml:lang="ru">Трансплантология</journal-title><trans-title-group xml:lang="en"><trans-title>Transplantologiya. The Russian Journal of Transplantation</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2074-0506</issn><issn pub-type="epub">2542-0909</issn><publisher><publisher-name>IPO Association of Transplantologists</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.23873/2074-0506-2021-13-2-141-150</article-id><article-id custom-type="elpub" pub-id-type="custom">transplantologiya-571</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>АКТУАЛЬНЫЕ ВОПРОСЫ ТРАНСПЛАНТОЛОГИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ACTUAL ISSUES OF TRANSPLANTATION</subject></subj-group></article-categories><title-group><article-title>Особенности субпопуляционного состава В-лимфоцитов у реципиентов почечного трансплантата</article-title><trans-title-group xml:lang="en"><trans-title>Characteristics of B-lymphocyte subpopulations in renal transplant recipients</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3061-5324</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зыблева</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Zybleva</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Светлана Валерьевна Зыблева, канд. мед. наук, врач-иммунолог, ученый секретарь</p><p>246040, Гомель, ул. Ильича, д. 290</p></bio><bio xml:lang="en"><p>Svetlana V. Zybleva, Cand. Sci. (Med.), Immunologist, Academic Secretary</p><p>290 Il’ich St., Gomel 246040</p></bio><email xlink:type="simple">zyb-svetlana@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0968-6630</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зыблев</surname><given-names>С. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Zyblev</surname><given-names>S. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сергей Леонидович Зыблев, канд. мед. наук, доцент, врач-хирург хирургического отделения (трансплантации, реконструктивной и эндокринной хирургии)</p><p>246040, Гомель, ул. Ильича, д. 290</p></bio><bio xml:lang="en"><p>Sergey L. Zyblev, Cand. Sci. (Med.), Associate Professor, Surgeon of Transplantation, Endocrine and Reconstructive Surgery Department</p><p>290 Il’ich St., Gomel 246040</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ГУ «Республиканский научно-практический центр радиационной медицины и экологии человека»</institution><country>Беларусь</country></aff><aff xml:lang="en"><institution>Republican Research Center for Radiation Medicine and Human Ecology</institution><country>Belarus</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>19</day><month>06</month><year>2021</year></pub-date><volume>13</volume><issue>2</issue><fpage>141</fpage><lpage>150</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Зыблева С.В., Зыблев С.Л., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Зыблева С.В., Зыблев С.Л.</copyright-holder><copyright-holder xml:lang="en">Zybleva S.V., Zyblev S.L.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.jtransplantologiya.ru/jour/article/view/571">https://www.jtransplantologiya.ru/jour/article/view/571</self-uri><abstract><p>Введение. Обнаружено существование многочисленных подмножеств B-клеток со специфическими нормативными функциями, способными к модулированию воспалительных ответов. Большинство исследований по изучению функции B-регуляторных лимфоцитов проводили в контексте аутоиммунной и инфекционной патологии, тогда как целью данной работы было изучить показатели основных, активированных и толерогенных субпопуляций В-лимфоцитов у пациентов, перенесших трансплантацию почки.Цель исследования. Изучить показатели субпопуляций В-лимфоцитов и определить их роль в развитии иммунологической толерантности после трансплантации почки.Материал и методы. Обследованы 197 реципиентов почечного трансплантата. Определяли уровень субпопуляций В-лимфоцитов (CD19+IgD+CD27+ и CD19+IgD-CD27+) перед операцией, на 1-е, 3-и, 7-е и 30-е сутки после операции. Функцию почечного трансплантата оценивали на 7-е сутки с разделением пациентов на две группы: с первичной функцией и его дисфункцией.Результаты и обсуждение. В показателях CD19+IgD+CD27+ и CD19+IgD-CD27+ на протяжении 3 месяцев выявлены статистически значимые отличия между группами реципиентов. В течение первых 7 суток с удовлетворительной функцией аллотрансплантата ассоциированы более низкие уровни данных субпопуляций. Однако к 90-м суткам после операции в группе пациентов с дисфункцией трансплантата отмечен рост показателей CD19+IgD+CD27+ В-лимфоцитов.Выводы. Низкие уровни непереключенных (CD19+IgD+CD27+) и переключенных (CD19+IgD-CD27+) В-лимфоцитов памяти в периферической крови реципиентов почечного трансплантата ассоциированы с благоприятным вариантом течения раннего послеоперационного периода. Выявлено, что на 3-и посттрансплантационные сутки относительный уровень CD19+IgD+CD27+ непереключенных В-лимфоцитов памяти, более либо равный уровню 11,77% с чувствительностью 88,40% и специфичностью 84,30%, и уровень CD19+IgD-CD27+ переключенных В-лимфоцитов памяти, более либо равный значению 20,74% с чувствительностью 88,70% и специфичностью 82,40%, позволяют прогнозировать развитие ранней дисфункции почечного трансплантата.</p></abstract><trans-abstract xml:lang="en"><p>Introduction. The presence of multiple subsets of B-cells with specific regulatory functions capable of modulating inflammatory responses havebeen detected. Most of the studies of Bregs function were carried out in the context of autoimmune and infectious diseases, whereas the objective of this research was to study the characteristics of the main, activated and tolerogenic subpopulations of B lymphocytes in patients who underwent kidney transplantation. Objective. To study the indices of B-lymphocyte subpopulations and determine their role in the development of immunological tolerance after kidney transplantation.Material and methods. We have examined 197 recipients who underwent kidney transplantation. We determined B lymphocyte subpopulation levels (CD19+IgD+CD27+ and CD19+IgD-CD27+) before transplantation, on the 1st, 3rd, 7th and 30th days after the transplantation. Allograft function was assessed on day 7 with the division of patients into two groups: with primary graft function and graft dysfunction.Results and discussion. Significant differences were revealed between the groups of recipients over three months in the following cell subpopulation levels CD19+IgD+CD27+ and CD19+IgD-CD27+. During the first 7 days, lower levels of these subpopulations were associated with satisfactory allograft function. However, by the 90th day after surgery, an increase in CD19+IgD+CD27+ B lymphocytes was noted in the group of patients with graft dysfunction.Conclusions. Low levels of not-switched (CD19+IgD+CD27+) and switched (CD19+IgD-CD27+) memory В lymphocytes in the peripheral blood of kidney transplant recipients are associated with a favorable postoperative course. We have found that on the 3rd post-transplant day, the relative level of non-switched memory B lymphocytes (CD19+IgD+CD27+) exceeding or equal to 11.47%, and the level of switched memory B lymphocytes (CD19+IgD-CD27+) exceeding or equal to 20.74% might predict the development of early renal graft dysfunction with a sensitivity and specificity of 88.40% and 84.30% for the former parameter and of 88.70% and 82.40% for the latter one, respectively.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>трансплантация почки</kwd><kwd>CD19+IgD+CD27+ и CD19+IgD-CD27+ В-лимфоциты</kwd><kwd>дисфункция трансплантата почки</kwd></kwd-group><kwd-group xml:lang="en"><kwd>kidney transplantation</kwd><kwd>CD19+IgD+CD27+ and CD19+IgD-CD27+ B lymphocytes</kwd><kwd>renal graft dysfunction</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Silva HM, Takenaka MC, Moraes-Vieira PM, Monteiro SM, Hernandez MO, Chaara W, et al. Preserving the B-cell compartment favors operational tolerance in human renal transplantation. Mol Med. 2012;18(1):733–743. PMID: 22252714 https://doi.org/10.2119/molmed.2011.00281</mixed-citation><mixed-citation xml:lang="en">Silva HM, Takenaka MC, Moraes-Vieira PM, Monteiro SM, Hernandez MO, Chaara W, et al. Preserving the B-cell compartment favors operational tolerance in human renal transplantation. Mol Med. 2012;18(1):733–743. PMID: 22252714 https://doi.org/10.2119/molmed.2011.00281</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Samitas K, Lötvall J, Bossios A. B cells: from early development to regulating allergic diseases. Arch Immunol Ther Exp (Warsz). 2010;58(3):209–225. PMID: 20458549 https://doi.org/10.1007/s00005-010-0073-2</mixed-citation><mixed-citation xml:lang="en">Samitas K, Lötvall J, Bossios A. B cells: from early development to regulating allergic diseases. Arch Immunol Ther Exp (Warsz). 2010;58(3):209–225. PMID: 20458549 https://doi.org/10.1007/s00005-010-0073-2</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Vaughan AT, Roghanian A, Cragg MS. B cells-masters of the immunoverse. Int J Biochem Cell Biol. 2011;43(3):280–285. PMID: 21147251 https://doi.org/10.1016/j.biocel.2010.12.005</mixed-citation><mixed-citation xml:lang="en">Vaughan AT, Roghanian A, Cragg MS. B cells-masters of the immunoverse. Int J Biochem Cell Biol. 2011;43(3):280–285. PMID: 21147251 https://doi.org/10.1016/j.biocel.2010.12.005</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Sims GP, Ettinger R, Shirota Y, Yarboro CH, Illei GG, Lipsky PE. Identification and characterization of circulating human transitional B cells. Blood. 2005;105(11):4390–4398. PMID: 15701725 https://doi.org/10.1182/blood-2004-11-4284</mixed-citation><mixed-citation xml:lang="en">Sims GP, Ettinger R, Shirota Y, Yarboro CH, Illei GG, Lipsky PE. Identification and characterization of circulating human transitional B cells. Blood. 2005;105(11):4390–4398. PMID: 15701725 https://doi.org/10.1182/blood-2004-11-4284</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Wortel CM, Heidt S. Regulatory B cells: Phenotype, function and role in transplantation. Transpl Immunol. 2017;41:1–9. PMID: 28257995 https://doi.org/10.1016/j.trim.2017.02.004</mixed-citation><mixed-citation xml:lang="en">Wortel CM, Heidt S. Regulatory B cells: Phenotype, function and role in transplantation. Transpl Immunol. 2017;41:1–9. PMID: 28257995 https://doi.org/10.1016/j.trim.2017.02.004</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Lindenau S, Scholze S, Odendahl M, Dörner T, Radbruch A, Burmester GR, et al. Aberrant activation of B cells in patients with rheumatoid arthri tis. Ann NY Acad Sci. 2003;987:246–248. PMID: 12727646 https://doi.org/10.1111/j.1749-6632.2003.tb06055.x</mixed-citation><mixed-citation xml:lang="en">Lindenau S, Scholze S, Odendahl M, Dörner T, Radbruch A, Burmester GR, et al. Aberrant activation of B cells in patients with rheumatoid arthri tis. Ann NY Acad Sci. 2003;987:246–248. PMID: 12727646 https://doi.org/10.1111/j.1749-6632.2003.tb06055.x</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Brezinschek HP, Rainer F, Brick mann K, Graninger WB. B lymphocyte-typing for prediction of clinical response to rituximab. Arthritis Res Ther. 2012;14(4):R161. PMID: 22770118 https://doi.org/10.1186/ar3901</mixed-citation><mixed-citation xml:lang="en">Brezinschek HP, Rainer F, Brick mann K, Graninger WB. B lymphocyte-typing for prediction of clinical response to rituximab. Arthritis Res Ther. 2012;14(4):R161. PMID: 22770118 https://doi.org/10.1186/ar3901</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Зыблева С.В., Зыблев С.Л., Мар тинков В.Н. Показатели субпопуляционного состава лимфоцитов для прогноза дисфункции почечного аллотрансплантата. Трансплантология. 2020;12(3):189–198. https://doi.org/10.23873/2074-0506-2020-12-3-189-198</mixed-citation><mixed-citation xml:lang="en">Zybleva SV, Zyblev SL, Martinkov VN. Studying some lymphocyte subpopulations in search for predictors of renal graft dysfunction. Transplantologiya. The Russian Journal of Transplantation. 2020;12(3):189–198. (In Russ.). https://doi.org/10.23873/2074-0506-2020-12-3-189-198</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Cantaluppi V, Dellepiane S, Tamagnone M, Medica D, Figliolini F, Messina M, et al. Neutrophil gelatinase associated lipocalin is an early and accurate biomarker of graft function and tissue regeneration in kidney transplanta tion from extended criteria donors. PLoS One. 2015;10(6):e0129279. PMID: 26125566 https://doi.org/10.1371/journal.pone.0129279</mixed-citation><mixed-citation xml:lang="en">Cantaluppi V, Dellepiane S, Tamagnone M, Medica D, Figliolini F, Messina M, et al. Neutrophil gelatinase associated lipocalin is an early and accurate biomarker of graft function and tissue regeneration in kidney transplanta tion from extended criteria donors. PLoS One. 2015;10(6):e0129279. PMID: 26125566 https://doi.org/10.1371/journal.pone.0129279</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Sellam J, Rouanet S, HendelChavez H, Abbed K, Sibilia J, Tebib J, et al. Blood memory B cells are disturbed and predict the response to rituximab in patients with rheumatoid arthritis. Arthritis Rheum. 2011;63(12):3692-3701. PMID: 22127692 https://doi.org/10.1002/art.30599</mixed-citation><mixed-citation xml:lang="en">Sellam J, Rouanet S, HendelChavez H, Abbed K, Sibilia J, Tebib J, et al. Blood memory B cells are disturbed and predict the response to rituximab in patients with rheumatoid arthritis. Arthritis Rheum. 2011;63(12):3692-3701. PMID: 22127692 https://doi.org/10.1002/art.30599</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Anolik JH, Barnard J, Cappione A, Pugh-Bernard AE, Felgar RE, Looney RJ, et al. Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus. Arthritis Rheum. 2004;50(11):3580–3590. PMID: 15529346 https://doi.org/10.1002/art.20592</mixed-citation><mixed-citation xml:lang="en">Anolik JH, Barnard J, Cappione A, Pugh-Bernard AE, Felgar RE, Looney RJ, et al. Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus. Arthritis Rheum. 2004;50(11):3580–3590. PMID: 15529346 https://doi.org/10.1002/art.20592</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Jacobi AM, Reiter K, Mackay M, Aranow C, Hiepe F, Radbruch A, et al. Activated memory B cell subsets cor relate with disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD, and CD95. Arthritis Rheum. 2008;58(6):1762-1773. PMID: 18512812 https://doi.org/10.1002/art.23498</mixed-citation><mixed-citation xml:lang="en">Jacobi AM, Reiter K, Mackay M, Aranow C, Hiepe F, Radbruch A, et al. Activated memory B cell subsets cor relate with disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD, and CD95. Arthritis Rheum. 2008;58(6):1762-1773. PMID: 18512812 https://doi.org/10.1002/art.23498</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Супоницкая Е.В., Алексанкин А.П., Александрова Е.Н., Авдеева А.С., Панафидина Т.А., Верижникова Ж.Г. и др. Определение субпопуляций В-лимфоцитов периферической крови методом проточной цитофлуорометрии у здоровых лиц и больных ревматическими заболеваниями. Клиническая лабораторная диагностика. 2015;60(6):30–33.</mixed-citation><mixed-citation xml:lang="en">Suponitskaia EV, Aleksankin AP, Aleksandrova EN, Avdeeva AS, Panafidina TA, Verijnikova JG, et al. The identification of subpopulations of B-lymphocytes of peripheral blood using technique of flow cytofluorometry in healthy individuals and patients with rheumatoid diseases. Klinicheskaia Laboratornaia Diagnostika. 2015;60(6):30–33. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Adlowitz DG, Barnard J, Biear JN, Cistrone C, Owen T, Wang W, et al. Expansion of activated peripheral blood memory b cells in rheumatoid arthritis, impact of b cell depletion therapy, and biomarkers of response. PLoS One. 2015;10(6):e0128269. PMID: 26047509 https://doi.org/10.1371/journal.pone.0128269</mixed-citation><mixed-citation xml:lang="en">Adlowitz DG, Barnard J, Biear JN, Cistrone C, Owen T, Wang W, et al. Expansion of activated peripheral blood memory b cells in rheumatoid arthritis, impact of b cell depletion therapy, and biomarkers of response. PLoS One. 2015;10(6):e0128269. PMID: 26047509 https://doi.org/10.1371/journal.pone.0128269</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Miller ML, Chong AS, Alegre ML. Mechanisms underlying transplantation tolerance. Reference Module in Biomedical Sciences. Elsevier; 2014. https://doi.org/10.1016/B978-0-12-801238-3.00127-6</mixed-citation><mixed-citation xml:lang="en">Miller ML, Chong AS, Alegre ML. Mechanisms underlying transplantation tolerance. Reference Module in Biomedical Sciences. Elsevier; 2014. https://doi.org/10.1016/B978-0-12-801238-3.00127-6</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Turka LA, Lechler RI. Towards the identification of biomarkers of trans plantation tolerance. Nat Rev Immu nol. 2009;9(7):521–526. PMID: 19483711 https://doi.org/10.1038/nri2568</mixed-citation><mixed-citation xml:lang="en">Turka LA, Lechler RI. Towards the identification of biomarkers of trans plantation tolerance. Nat Rev Immu nol. 2009;9(7):521–526. PMID: 19483711 https://doi.org/10.1038/nri2568</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Matsushita T, Yanaba K, Bouaziz JD, Fujimoto M, Tedder TF. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest. 2008;118(10):34203430. PMID: 18802481 https://doi.org/10.1172/JCI36030</mixed-citation><mixed-citation xml:lang="en">Matsushita T, Yanaba K, Bouaziz JD, Fujimoto M, Tedder TF. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest. 2008;118(10):34203430. PMID: 18802481 https://doi.org/10.1172/JCI36030</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
